DYNAVAX TECHNOLOGIES CORP's ticker is and the CUSIP is 268158901. A total of 4 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,575 | +29.4% | 106,700 | +13.3% | 0.00% | 0.0% |
| Q2 2023 | $1,217 | +28.4% | 94,200 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $948 | -42.0% | 96,700 | -37.0% | 0.00% | -50.0% |
| Q4 2022 | $1,634 | -99.9% | 153,600 | -4.4% | 0.00% | 0.0% |
| Q3 2022 | $1,676,000 | -41.2% | 160,600 | -29.1% | 0.00% | -33.3% |
| Q2 2022 | $2,850,000 | +38.2% | 226,400 | +19.0% | 0.00% | +50.0% |
| Q1 2022 | $2,062,000 | -30.3% | 190,300 | -9.6% | 0.00% | -33.3% |
| Q4 2021 | $2,960,000 | +45.0% | 210,400 | +5.4% | 0.00% | +50.0% |
| Q3 2021 | $2,042,000 | +9.3% | 199,700 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $1,869,000 | – | 189,800 | +10432.7% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 1,802 | -11.2% | 0.00% | -100.0% |
| Q4 2020 | $903,000 | -5.4% | 2,030 | -8.2% | 0.00% | 0.0% |
| Q3 2020 | $955,000 | -48.9% | 2,211 | +4.8% | 0.00% | -66.7% |
| Q2 2020 | $1,870,000 | +3239.3% | 2,109 | +1209.9% | 0.00% | – |
| Q1 2020 | $56,000 | -72.5% | 161 | -55.0% | 0.00% | – |
| Q4 2019 | $204,000 | -24.2% | 358 | -52.6% | 0.00% | -100.0% |
| Q3 2019 | $269,000 | +289.9% | 755 | +331.4% | 0.00% | – |
| Q2 2019 | $69,000 | -34.3% | 175 | +21.5% | 0.00% | – |
| Q1 2019 | $105,000 | -67.7% | 144 | -59.6% | 0.00% | -100.0% |
| Q4 2018 | $325,000 | +66.7% | 356 | +125.3% | 0.00% | 0.0% |
| Q3 2018 | $195,000 | +59.8% | 158 | +97.5% | 0.00% | – |
| Q2 2018 | $122,000 | -49.0% | 80 | -98.6% | 0.00% | -100.0% |
| Q1 2018 | $239,000 | +134.3% | 5,564 | +563.2% | 0.01% | +175.0% |
| Q4 2017 | $102,000 | -63.8% | 839 | +64.8% | 0.00% | -66.7% |
| Q3 2017 | $282,000 | -46.7% | 509 | -69.8% | 0.01% | -47.8% |
| Q2 2017 | $529,000 | +487.8% | 1,683 | +91.2% | 0.02% | +475.0% |
| Q1 2017 | $90,000 | +900.0% | 880 | +99.5% | 0.00% | +300.0% |
| Q4 2016 | $9,000 | -87.8% | 441 | -59.1% | 0.00% | -80.0% |
| Q3 2016 | $74,000 | +15.6% | 1,077 | +111.2% | 0.01% | +25.0% |
| Q2 2016 | $64,000 | +700.0% | 510 | +764.4% | 0.00% | +300.0% |
| Q1 2016 | $8,000 | -27.3% | 59 | -65.9% | 0.00% | 0.0% |
| Q4 2015 | $11,000 | -47.6% | 173 | -20.3% | 0.00% | -50.0% |
| Q3 2015 | $21,000 | +40.0% | 217 | +404.7% | 0.00% | +100.0% |
| Q2 2015 | $15,000 | -76.9% | 43 | -61.9% | 0.00% | -87.5% |
| Q1 2015 | $65,000 | – | 113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 521,800 | $10,024,000 | 0.30% |
| GROUP ONE TRADING, L.P. | 433,800 | $8,333,000 | 0.01% |
| SIMPLEX TRADING, LLC | 199,700 | $2,042,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |